CA

Florence W H Ng

This inventor holds 2 USPTO granted patents. Top assignee: Mcgill University. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Florence W H Ng. Retrieved from https://idiyas.com/inventor/florence-w-h-ng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Quebec, CA (2003)
  • Boston, MA (US) (2003)

Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Florence W H Ng: Innovator in Apoptosis Modulation

Introduction

Florence W H Ng is a prominent inventor based in California, known for his significant contributions to the field of apoptosis modulation. With a total of 2 patents, he has made strides in understanding and manipulating the processes of cell death, which has implications for various medical applications.

Latest Patents

Ng's latest patents focus on methods and reagents for modulating apoptosis. The first patent introduces a novel apoptosis protein known as p28 Bap31. This invention includes p28 Bap31 polypeptide fragments, antisense nucleic acid molecules, anti-p28 Bap31 antibodies, and methods for both modulating apoptosis and detecting compounds that influence this process. The second patent also features p28 Bap31 polypeptides and nucleic acids, along with methods for modulating apoptosis using these components and identifying compounds that modulate apoptosis.

Career Highlights

Florence W H Ng is affiliated with McGill University, where he continues to advance research in his field. His work has garnered attention for its potential applications in therapeutic interventions.

Collaborations

Ng has collaborated with notable colleagues, including Gordon C Shore and Mai Nguyen, contributing to a rich environment of innovation and research.

Conclusion

Florence W H Ng's work in apoptosis modulation showcases his dedication to advancing scientific knowledge and developing new therapeutic strategies. His patents reflect a commitment to innovation that could have lasting impacts in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…